8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________

FORM 8-K

_______________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 14, 2021

_____________________________________

SelectQuote, Inc.

(Exact name of registrant as specified in its charter)

_____________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 14, 2021, SelectQuote, Inc. (the “Company”) announced the appointment of Robert Grant, 37, as the President of the Company, effective October 28, 2021 (the “Effective Date”). Mr. Grant currently serves as the President of the Company’s Senior Division and will continue in this role until the Effective Date. Mr. Grant previously served as the Company’s Chief Revenue Officer from 2017 to 2019, the Senior Vice President of Sales of the Company’s Life Division from 2016 to 2017, and as the Director of Sales and Operations for the Company’s Senior Division from 2013 to 2016. There is no arrangement or understanding between Mr. Grant and any other person pursuant to which he was appointed as President.

No changes to Mr. Grant’s compensation arrangements or employment agreement with the Company will be made in connection with his appointment as President. Mr. Grant’s current compensation arrangements and employment agreement are described in the Company’s definitive proxy statement, filed with the Securities and Exchange Commission on September 27, 2021 (the “Proxy Statement”), in which he is included as a named executive officer.

Mr. Grant is the son of William Grant II, the Vice Chairman of the Company’s Board of Directors, and the brother of William Grant III, the Company’s Chief Operating Officer. All transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K in which Mr. Grant has an interest are described in the Proxy Statement under the heading “Certain Relationships and Related Party Transactions.”

A copy of the press release announcing the appointment of Mr. Grant as President is attached to this report as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Document

6800 West 115th Street, Suite 2511, Overland Park, KS 66211

selectquote.com

SELECTQUOTE NAMES ROBERT GRANT PRESIDENT

OVERLAND PARK, Kan. (Oct. 14, 2021) –SelectQuote, Inc. (NYSE: SLQT) today announced that its Board of Directors has promoted Robert “Bob” Grant to the role of President of SelectQuote, effective Oct. 28, 2021.

“Bob has earned this promotion with the success SelectQuote has experienced in our Senior Division and with the addition of our Population Health platform that provides great synergy with our core Medicare business,” said Tim Danker, CEO. “Bob’s leadership, not only in the Senior Division but across other areas of our business, has been critically important in helping our company profitably grow and scale. The Board of Directors and I could not be happier for Bob in this expanded role.”

Mr. Grant has been instrumental in the development of Population Health, a healthcare services platform, and SelectRx, which were unveiled in May to help Medicare Advantage customers lead healthier lives by assisting them in better utilizing their plan benefits and simplifying their medication experience through education and medication management.

Mr. Grant, who received his undergraduate degree from the University of Kansas, has been the President of SelectQuote’s Senior Division since 2019, and was previously the Company’s Chief Revenue Officer from 2017-2019. He has also served as Senior Vice President of Sales for the Life Division, and as the Director of Sales and Operations for the Senior Division.

About SelectQuote:

Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. SelectQuote pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin the company’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. SelectQuote has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. In 2021, SelectQuote expanded its business with the addition of Population Health, a healthcare services company, and SelectRx, a specialty medication management pharmacy.

Page 2 of 2